Walleye Capital
IONS icon

Walleye Capital’s Ionis Pharmaceuticals IONS Stock Holding History

Walleye Capital’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$159 Sell
2
-65,947
-100% -$4.96M ﹤0.01% 4635
2026
Q1 		$4.95M Buy
65,949
+65,624
+20,192% +$5.18M 0.02% 809
2025
Q4 		$25.7K Buy
+325
New +$24.5K ﹤0.01% 4215
2025
Q3 		– Sell
-66,482
Closed -$3.25M – 4798
2025
Q2 		$2.63M Sell
66,482
-28,508
-30% -$933K 0.01% 1310
2025
Q1 		$2.87M Buy
94,990
+78,735
+484% +$2.58M 0.01% 1178
2024
Q4 		$568K Sell
16,255
-107,861
-87% -$4.03M ﹤0.01% 2880
2024
Q3 		$4.97M Buy
124,116
+26,245
+27% +$1.22M 0.01% 1170
2024
Q2 		$4.66M Buy
97,871
+8,741
+10% +$359K 0.01% 1343
2024
Q1 		$3.86M Buy
+89,130
New +$4.25M 0.01% 1495
2023
Q2 		– Sell
-2,240
Closed -$86.1K – 4576
2023
Q1 		$80.1K Sell
2,240
-23,814
-91% -$894K ﹤0.01% 3041
2022
Q4 		$984K Sell
26,054
-59,909
-70% -$2.52M 0.02% 1011
2022
Q3 		$3.8M Buy
85,963
+79,594
+1,250% +$3.35M 0.07% 292
2022
Q2 		$236K Buy
+6,369
New +$240K 0.01% 1440
2021
Q4 		– Sell
-15,470
Closed -$519K – 2199
2021
Q3 		$519K Buy
+15,470
New +$583K 0.01% 774
2019
Q3 		– Sell
-170
Closed -$11.1K – 2053
2019
Q2 		$11K Sell
170
-1,490
-90% -$105K ﹤0.01% 1584
2019
Q1 		$135K Buy
+1,660
New +$107K 0.02% 920

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Walleye Capital's IONS Position: Q2 2026 in Review

Walleye Capital reduced its Ionis Pharmaceuticals (IONS) stake by 100% in Q2 2026, selling an estimated $4.96M and leaving 2 shares worth $159. The position accounts for ﹤0.01% of the portfolio, ranked #4635.

Walleye Capital first reported a position in IONS in Q1 2019 and has held it in 16 quarters since. The position peaked at $4.97M in Q3 2024. 514 funds tracked by Wall St. Rank hold IONS as of Q2 2026.

  • Walleye Capital held 2 shares of Ionis Pharmaceuticals worth $159 as of Q2 2026.
  • Walleye Capital sold 65,947 Ionis Pharmaceuticals shares in Q2 2026, an estimated $4.96M.
  • Ionis Pharmaceuticals made up ﹤0.01% of Walleye Capital's portfolio in Q2 2026, its #4635 holding.
  • Walleye Capital first reported a position in Ionis Pharmaceuticals in Q1 2019 and has held it in 16 quarters since.
  • Walleye Capital's Ionis Pharmaceuticals position peaked at $4.97M in Q3 2024.
  • 514 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q2 2026.

Based on Walleye Capital's 13F filing for Q2 2026, filed 3 Aug 2026.